Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment

The effect of hepatic impairment on fosamprenavir/ritonavir pharmacokinetics was investigated. Sixty human immunodeficiency virus type 1-infected subjects, including 13, 20, and 10 subjects with mild, moderate, and severe hepatic impairment, respectively, and a comparator group of 17 subjects with n...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pérez-Elías, María J., Morellon, María Larrousse, Ortega, Enrique, Hernández-Quero, José, Rodríguez-Torres, Maribel, Clotet, Bonaventura, Felizarta, Franco, Gutiérrez, Felix, Pineda, Juan A., Nichols, Garrett, Lou, Yu, Wire, Mary Beth
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2009
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786343/
https://ncbi.nlm.nih.gov/pubmed/19667283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00632-09
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky